Sign up to save your podcasts
Or
Share Discussing the Role of MRD in CLL With Talal Hilal, MD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Discussing the Role of MRD in CLL With Talal Hilal, MD
Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).
View all episodes
By Rahul Banerjee, MD
4.8
2626 ratings
Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
138 Listeners
Research To Practice | Oncology Videos
116 Listeners
Making Sense with Sam Harris
26,355 Listeners
The Hematologist
28 Listeners
OncoPharm
184 Listeners
VJHemOnc Podcast
2 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Blood Podcast
54 Listeners
The Curious Clinicians
372 Listeners
Healthcare Unfiltered
136 Listeners
ASTCT Talks
9 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
185 Listeners
Blood Cancer Talks
49 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners